Related references
Note: Only part of the references are listed.Analytical methods to assess nanoparticle toxicity
Bryce J. Marquis et al.
ANALYST (2009)
Targeted Herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2/neu receptors using MRI
Ting-Jung Chen et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
Achuthamangalam B. Madhankumar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Nanotechnology and cancer
James R. Heath et al.
ANNUAL REVIEW OF MEDICINE (2008)
Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates
Andrzej Myc et al.
ANTI-CANCER DRUGS (2008)
Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status
Neil P. Desai et al.
ANTI-CANCER DRUGS (2008)
Rapid distribution of liposomal short-chain ceramide in vitro and in vivo
Banu S. Zolnik et al.
DRUG METABOLISM AND DISPOSITION (2008)
Pharmacokinetics and In Vivo Drug Release Rates in Liposomal Nanocarrier Development
Daryl C. Drummond et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Evaluation of poly (glycerol-adipate) nanoparticle uptake in an In Vitro 3-D brain tumor co-culture model
W. Meng et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Wee Beng Tan et al.
BIOMATERIALS (2007)
In vivo antitumor activity of chitosan nanoparticles
Lifeng Qi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent
P Bourrinet et al.
INVESTIGATIVE RADIOLOGY (2006)
Pros and cons of the liposome platform in cancer drug targeting
Alberto A. Gabizon et al.
JOURNAL OF LIPOSOME RESEARCH (2006)
In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size
C Fang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice
LH Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Nanotoxicology:: An emerging discipline evolving from studies of ultrafine particles
G Oberdörster et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2005)
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer
JF Kukowska-Latallo et al.
CANCER RESEARCH (2005)
Antiangiogenic properties of gold nanoparticles
P Mukherjee et al.
CLINICAL CANCER RESEARCH (2005)
Nanomedicine: current status and future prospects
SM Moghimi et al.
FASEB JOURNAL (2005)
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
R Satchi-Fainaro et al.
NATURE MEDICINE (2004)
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Y Matsumura et al.
BRITISH JOURNAL OF CANCER (2004)
Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins
J Seki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells
Swayam Prabha et al.
MOLECULAR PHARMACEUTICS (2004)
Molecular imaging of angiogenesis in early-stage atherosclerosis with αvβ3-Integrin-targeted nanoparticles
PM Winter et al.
CIRCULATION (2003)
In vivo near-infrared fluorescence imaging
JV Frangioni
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Tumor regression by targeted gene delivery to the neovasculature
JD Hood et al.
SCIENCE (2002)
Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models
K Lode et al.
PHARMACEUTICAL RESEARCH (2001)
Human transferrin receptor gene as a marker gene for MR imaging
A Moore et al.
RADIOLOGY (2001)
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel
JMM Terwogt et al.
ANTI-CANCER DRUGS (2001)
Pulsatile drug release from poly (lactide-co-glycolide) microspheres:: how does the composition of the polymer matrices affect the time interval between the initial burst and the pulsatile release of drugs?
K Makino et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2000)
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model
A Moore et al.
RADIOLOGY (2000)
Share Paper
